Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study.

Dreyfus, M

Successful long-term replacement therapy with FXIII concentrate (Fibrogammin(®) P) for severe congenital factor XIII deficiency: a prospective multicentre study. [electronic resource] - Journal of thrombosis and haemostasis : JTH Jun 2011 - 1264-6 p. digital

Publication Type: Clinical Trial; Letter; Multicenter Study

1538-7836

10.1111/j.1538-7836.2011.04281.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Factor XIII
Factor XIII Deficiency--congenital
Female
Fibrinolysin--therapeutic use
Fibrinolytic Agents
Humans
Infant
Male
Middle Aged
Young Adult